Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-10,334
Closed -$1.9M 134
2019
Q2
$1.9M Sell
10,334
-48
-0.5% -$8.6K 1.18% 29
2019
Q1
$1.97M Buy
10,382
+39
+0.4% +$7.45K 1.26% 27
2018
Q4
$2.01M Buy
10,343
+41
+0.4% +$8K 1.43% 23
2018
Q3
$2.14M Buy
10,302
+243
+2% +$47.9K 1.15% 23
2018
Q2
$1.86M Sell
10,059
-828
-8% -$146K 1.18% 30
2018
Q1
$1.86M Buy
10,887
+321
+3% +$58.9K 1.18% 28
2017
Q4
$1.84M Buy
10,566
+7
+0.1% +$1.24K 1.17% 29
2017
Q3
$1.97M Sell
10,559
-373
-3% -$66.1K 1.3% 22
2017
Q2
$1.88M Sell
10,932
-22
-0.2% -$3.58K 1.28% 23
2017
Q1
$1.8M Sell
10,954
-996
-8% -$165K 1.3% 23
2016
Q4
$1.75M Sell
11,950
-411
-3% -$61.9K 1.32% 21
2016
Q3
$2.06M Sell
12,361
-297
-2% -$50.2K 1.44% 13
2016
Q2
$1.93M Sell
12,658
-618
-5% -$96.1K 1.27% 22
2016
Q1
$1.99M Buy
13,276
+303
+2% +$45K 1.25% 20
2015
Q4
$2.11M Buy
12,973
+468
+4% +$73.6K 1.24% 17
2015
Q3
$1.73M Buy
+12,505
New +$1.97M 1.1% 26

Other funds holding AMGN

Kingfisher Capital's AMGN Position: Q3 2019 in Review

Kingfisher Capital sold out of Amgen (AMGN) in Q3 2019, closing a stake of 10,334 shares — an estimated $1.9M sold.

Kingfisher Capital first reported a position in AMGN in Q3 2015 and held it in 16 quarters. The position peaked at $2.14M in Q3 2018. 1,883 funds tracked by Wall St. Rank hold AMGN as of Q3 2019.

  • Kingfisher Capital reported no remaining Amgen position as of Q3 2019 after selling out during the quarter.
  • Kingfisher Capital sold 10,334 Amgen shares in Q3 2019, an estimated $1.9M.
  • Kingfisher Capital first reported a position in Amgen in Q3 2015 and held it in 16 quarters.
  • Kingfisher Capital's Amgen position peaked at $2.14M in Q3 2018.
  • 1,883 funds tracked by Wall St. Rank held Amgen as of Q3 2019.

Based on Kingfisher Capital's 13F filing for Q3 2019, filed 12 Nov 2019.